SecBot SecBot
SECBOTREPLAY Home › Report › BLFS

BLFS · BioLife Solutions filed an 8-K furnishing an investor presentation for…

BIOLIFE SOLUTIONS INC · 8-K filed Jun 3, 2026 at 08:03 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Jun 3, 2026 at 08:03 ET

BioLife Solutions filed an 8-K furnishing an investor presentation for the Jefferies Global Healthcare Conference. The presentation highlights FY2025 revenue of $96M (29% organic growth), 26% adjusted EBITDA margin, and provides 17-20% revenue growth guidance for FY2026, with expectations of positive GAAP net income for the full year. The filing is a routine investor relations update with no new material financial disclosures beyond previously reported figures.

  • FY2025 revenue of $96M with 29% organic growth
  • FY2025 adjusted EBITDA margin of 26%
  • FY2025 gross margin of 65%
  • 17-20% revenue growth guidance for FY2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access